Defluine (an association of raubasine and ergot derivatives) in the treatment of senile cerebral vascular diseases of a sclerotic nature
Turri, C.
Minerva Medica 61(65): 3466-3476
1970
ISSN/ISBN: 0026-4806 PMID: 5451093 Document Number: 29930
Document emailed within 1 workday
Related Documents
Kalmykov, M.Iu. 2014: Cerebral artery fenestrations: incidence, association with cerebral arterial aneurysms and other vascular diseases according to the data of multislice spiral computed tomography angiography Vestnik Rentgenologii i Radiologii 2014(2): 21-25Volterrani, U.; Baiotti, G. 1970: Cyclonamine ethamsilate in the treatment of atherosclerotic vascular diseases in the senile age, with spcial reference to the blood lipid level Minerva Medica 61(91): 5185-5194
Miragoli, G.; Ferrini, R. 1974: Effect of the combination of raubasine and hydrogenated ergot alkaloids on the isolated and perfused rat caudal artery and rabbit internal carotid artery Bollettino della Societa Italiana di Biologia Sperimentale 50(19): 1622-1628
Reuse-Blom, S. 1975: Action of defluine and its constituents on cerebral circulation in rabbits Bollettino Della Societa Italiana di Cardiologia 20(12): 1689-1692
Robbers, J.E.; Jones, L.G.; Krupinski, V.M. 1974: Ergot physiology. the production of ergot alkaloids in saprophytic culture by a homokaryotic strain of ergot Lloydia 37(1): 108-111
Müller-Schweinitzer, E.; Fanchamps, A. 1982: Effects on arterial receptors of ergot derivatives used in migraine Advances in Neurology 33: 343-356
Mercier, C. 1982: Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics Journal de Pharmacie de Belgique 37(4): 289-298
Jolivet, A.; Robyn, C.; Huraux-Rendu, C.; Gautray, J.P. 1978: Effect of ergot alkaloid derivatives on milk secretion in the immediate postpartum period Journal de Gynecologie Obstetrique et Biologie de la Reproduction 7(1): 129-134
Provost, J.; Hardy, J. 1970: Microsurgery in cerebral vascular diseases L'Union Medicale du Canada 99(5): 834-835
Gorini, A.; Arnaboldi, R.; Vercesi, L.; Dossena, M. 1988: Influence of some ergot alkaloids on the cerebral reduced glutathione Il Farmaco; Edizione Scientifica 43(11): 887-890
De Candia, O.; Bartolucci, E.; Mancinella, A.; Baghiris, D. 1979: Vincamine in the therapy of cerebral vascular diseases in the aged La Clinica Terapeutica 89(4): 373-380
Antonini, F.M.; Baroni, A.; Marcon, G. 1976: Controlled trial of piribedil (ET 495) in cerebral vascular diseases Minerva Medica 67(26): 1740-1744
Vaupel, P.; Hutten, H. 1980: Acute changes in intracerebral vascular resistance after application of dihydrogenated ergot alkaloids Arzneimittel-Forschung 30(4): 598-602
Kaminskii, I.V.; Shevchenko, V.N. 1975: Morphohistochemical changes in cerebral vascular plexi in connective tissue diseases Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 75(7): 986-989
Rappelli, A.; Catalini, R.; Dessi Fulgheri, P.; Sturbini, S. 1988: Arterial hypertension and cerebral vascular diseases: therapeutic implications Cardiologia 33(12): 1145-1149
Bona, G.; Silvestro, L.; Mussa, G.C. 1982: Angioscintigraphic examinations in the study of cerebral vascular diseases in children Minerva Pediatrica 34(15-16): 651-658
Silvestrini, P.; Raso, A.M. 1972: Peridural anesthesia in vascular surgery. I. use of it in surgical treatment of peripheral vascular diseases Chirurgia 21(7): 651-657
Akimov, G.A.; Lobzin, V.S.; Sapov, I.A.; Ter-Karapetian, V.A. 1980: Effectiveness of oxygen barotherapy in the initial forms of cerebral vascular diseases Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 80(7): 1012-1016
Petronio, G.; Scali, G.; Casa, B.; Nonis, E. 1980: Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients La Clinica Terapeutica 94(4): 427-444
Asano, T.; Hidaka, H. 1990: New pharmacological strategies in vascular diseases: a novel intracellular calcium antagonist, HA1077 (AT-877) and cerebral vasospasm Methods and Findings in Experimental and Clinical Pharmacology 12(6): 443-448